Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 11,432 |
| Receivables | 3,908 |
| Other current assets | 909 |
| TOTAL | $16,249 |
| Non-Current Assets | |
| PPE Net | 768 |
| TOTAL | $768 |
| Total Assets | $19,043 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 3,889 |
| Accrued Expenses | 1,421 |
| Other current liabilities | 270 |
| TOTAL | $5,752 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 33,765 |
| TOTAL | $33,765 |
| Total Liabilities | $41,122 |
| Shareholders' Equity | |
| Retained earnings | -37,885 |
| Other shareholders' equity | -100 |
| TOTAL | $-22,079 |
| Total Liabilities And Equity | $19,043 |